Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Nash

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2001
Severe canine hereditary hemolytic anemia treated by nonmyeloablative marrow transplantationJ A Zaucha, C Yu, C D Lothrop, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 29, 1999
Relationship of tacrolimus (FK506) whole blood concentrations and efficacy and safety after HLA-identical sibling bone marrow transplantationJ R Wingard, R A Nash, D Przepiorka, et al.
Blood|July 27, 1999
Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantationR Storb, C Yu, T Barnett, et al.
Transplantation|July 15, 1995
A toxicity study of trimetrexate used in combination with cyclosporine as acute graft-versus-host disease prophylaxis in HLA-mismatched, related donor bone marrow transplantsK C Doney, R Storb, K Beach, et al.
Bone Marrow Transplantation|April 30, 2014
Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantationC Castilla-Llorente, P J Martin, G B McDonald, et al.
Blood|April 16, 1998
Characterization of monoclonal antibodies that recognize canine CD34P A McSweeney, K A Rouleau, P M Wallace, et al.
Transplantation Proceedings|February 1, 1995
FK 506-based immunosuppression for prevention of graft versus host disease after unrelated donor marrow transplantationJ W Fay, R A Nash, J R Wingard, et al.
Bone Marrow Transplantation|July 1, 1997
Lack of interaction between tacrolimus (FK506) and methotrexate in bone marrow transplant recipientsJ R Wingard, R A Nash, V Ratanatharathorn, et al.
Blood|November 23, 2000
Thalidomide for treatment of patients with chronic graft-versus-host diseaseS Koc, W Leisenring, M E Flowers, et al.
Blood|December 12, 2001
Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trialE Kansu, T Gooley, M E Flowers, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2001
Severe canine hereditary hemolytic anemia treated by nonmyeloablative marrow transplantationJ A Zaucha, C Yu, C D Lothrop, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 29, 1999
Relationship of tacrolimus (FK506) whole blood concentrations and efficacy and safety after HLA-identical sibling bone marrow transplantationJ R Wingard, R A Nash, D Przepiorka, et al.
Blood|July 27, 1999
Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantationR Storb, C Yu, T Barnett, et al.
Transplantation|July 15, 1995
A toxicity study of trimetrexate used in combination with cyclosporine as acute graft-versus-host disease prophylaxis in HLA-mismatched, related donor bone marrow transplantsK C Doney, R Storb, K Beach, et al.
Bone Marrow Transplantation|April 30, 2014
Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantationC Castilla-Llorente, P J Martin, G B McDonald, et al.
Blood|April 16, 1998
Characterization of monoclonal antibodies that recognize canine CD34P A McSweeney, K A Rouleau, P M Wallace, et al.
Transplantation Proceedings|February 1, 1995
FK 506-based immunosuppression for prevention of graft versus host disease after unrelated donor marrow transplantationJ W Fay, R A Nash, J R Wingard, et al.
Bone Marrow Transplantation|July 1, 1997
Lack of interaction between tacrolimus (FK506) and methotrexate in bone marrow transplant recipientsJ R Wingard, R A Nash, V Ratanatharathorn, et al.
Blood|November 23, 2000
Thalidomide for treatment of patients with chronic graft-versus-host diseaseS Koc, W Leisenring, M E Flowers, et al.
Blood|December 12, 2001
Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trialE Kansu, T Gooley, M E Flowers, et al.
Pageof 11